JP5340741B2 - 抗菌組成物 - Google Patents

抗菌組成物 Download PDF

Info

Publication number
JP5340741B2
JP5340741B2 JP2008545092A JP2008545092A JP5340741B2 JP 5340741 B2 JP5340741 B2 JP 5340741B2 JP 2008545092 A JP2008545092 A JP 2008545092A JP 2008545092 A JP2008545092 A JP 2008545092A JP 5340741 B2 JP5340741 B2 JP 5340741B2
Authority
JP
Japan
Prior art keywords
edta
composition
iodine
composition according
biofilm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008545092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519312A (ja
JP2009519312A5 (enExample
Inventor
スティーブン・エル・パーシバル
フィリップ・ジー・ボウラー
デイビッド・パーソンズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Convatec Technologies Inc
Original Assignee
Convatec Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convatec Technologies Inc filed Critical Convatec Technologies Inc
Publication of JP2009519312A publication Critical patent/JP2009519312A/ja
Publication of JP2009519312A5 publication Critical patent/JP2009519312A5/ja
Application granted granted Critical
Publication of JP5340741B2 publication Critical patent/JP5340741B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12—Iodine, e.g. iodophors; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/11—Peroxy compounds, peroxides, e.g. hydrogen peroxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/212—Peroxy acids, peracids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2008545092A 2005-12-14 2006-12-14 抗菌組成物 Expired - Fee Related JP5340741B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0525504.7 2005-12-14
GBGB0525504.7A GB0525504D0 (en) 2005-12-14 2005-12-14 Antimicrobial composition
PCT/GB2006/004691 WO2007068938A2 (en) 2005-12-14 2006-12-14 Antimicrobial composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013098416A Division JP2013209385A (ja) 2005-12-14 2013-05-08 抗菌組成物

Publications (3)

Publication Number Publication Date
JP2009519312A JP2009519312A (ja) 2009-05-14
JP2009519312A5 JP2009519312A5 (enExample) 2010-07-22
JP5340741B2 true JP5340741B2 (ja) 2013-11-13

Family

ID=35736154

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2008545092A Expired - Fee Related JP5340741B2 (ja) 2005-12-14 2006-12-14 抗菌組成物
JP2013098416A Pending JP2013209385A (ja) 2005-12-14 2013-05-08 抗菌組成物
JP2015200279A Active JP6348892B2 (ja) 2005-12-14 2015-10-08 抗菌組成物
JP2017112806A Active JP6509948B2 (ja) 2005-12-14 2017-06-07 抗菌組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013098416A Pending JP2013209385A (ja) 2005-12-14 2013-05-08 抗菌組成物
JP2015200279A Active JP6348892B2 (ja) 2005-12-14 2015-10-08 抗菌組成物
JP2017112806A Active JP6509948B2 (ja) 2005-12-14 2017-06-07 抗菌組成物

Country Status (14)

Country Link
US (3) US9149035B2 (enExample)
EP (2) EP1959739B1 (enExample)
JP (4) JP5340741B2 (enExample)
CA (1) CA2632939C (enExample)
DK (1) DK1959739T3 (enExample)
ES (1) ES2622827T3 (enExample)
GB (1) GB0525504D0 (enExample)
HK (1) HK1246086A1 (enExample)
HU (1) HUE032810T2 (enExample)
LT (1) LT1959739T (enExample)
NZ (1) NZ568999A (enExample)
PL (1) PL1959739T3 (enExample)
PT (1) PT1959739T (enExample)
WO (1) WO2007068938A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013209385A (ja) * 2005-12-14 2013-10-10 Convatec Technologies Inc 抗菌組成物

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007030931A1 (de) * 2007-07-03 2009-01-08 Birgit Riesinger Zusammensetzung, enthaltend mindestens einen nutritiven, mindestens einen desinfizierenden bzw. dekontaminierenden und/oder mindestens einen Proteasen hemmend wirkenden Wirkstoff und/oder Wirkstoffkomplex
GB0714338D0 (en) * 2007-07-23 2007-09-05 Sinclair Pharmaceuticals Ltd method
US20110189260A1 (en) * 2008-05-30 2011-08-04 University Of Cincinnati Use of zinc chelators to inhibit biofilm formation
US20100009009A1 (en) * 2008-07-10 2010-01-14 Micropure, Inc. Method and composition for prevention and treatment of oral fungal infections
US20100233101A1 (en) 2009-02-13 2010-09-16 Micropure, Inc. Composition and method for the oxidative consumption of salivary biomolecules
US8778387B2 (en) 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
MX2012008482A (es) 2010-01-22 2012-11-29 Hyprotek Inc Agentes antimicrobianos que comprenden peroxido, alcohol y agente quelatador.
WO2011105869A2 (ko) * 2010-02-26 2011-09-01 주식회사 나이벡 치아의 접합능을 향상시키기 위한 치과용 클린저 조성물
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
GB201105829D0 (en) * 2011-04-06 2011-05-18 Convatec Technologies Inc Antimicrobial compositions
US8829053B2 (en) * 2011-12-07 2014-09-09 Rochal Industries Llp Biocidal compositions and methods of using the same
US20130199946A1 (en) 2012-02-06 2013-08-08 Hyprotek, Inc. Portable Medical Device Protectors
MX2015007771A (es) 2012-12-20 2015-09-04 Convatec Technologies Inc Procesamiento de fibras celulosicas quimicamente modificadas.
WO2014100777A2 (en) * 2012-12-20 2014-06-26 Rajiv Bhushan Antimicrobial compositions
US10357470B2 (en) * 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
ES2894839T3 (es) * 2013-03-07 2022-02-16 Kane Biotech Inc Composiciones antimicrobianas antibiopelícula que comprenden EDTA disódico y sodio
GB201308770D0 (en) * 2013-05-15 2013-06-26 Convatec Technologies Inc Wound Dressing Comprising an Antimicrobial Composition
PT3104939T (pt) 2014-02-10 2024-07-17 Fred Hutchinson Cancer Center Tratamento de ataque cardíaco e lesão isquémica com iodeto de sódio
US20150272124A1 (en) 2014-03-25 2015-10-01 Ecolab Usa Inc. Antimicrobial compositions containing cationic active ingredients
EP3206698A4 (en) * 2014-10-15 2018-06-27 Biocide Pharma Inc. Methods and apparatus for treating sites of infection
GB2533975A (en) * 2014-12-30 2016-07-13 Trio Healthcare Ltd Antibiofilm compositions
SE1650162A1 (en) * 2016-02-09 2017-08-10 Karladani Abbas Antimicrobial and cleansing composition comprising a polymeric biguanide, EDTA, and surfactants.
WO2017180879A1 (en) 2016-04-13 2017-10-19 Sage Products, Llc Chg compatible composition and method
GB201607814D0 (en) * 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
JP6456897B2 (ja) 2016-10-05 2019-01-23 マルハニチロ株式会社 抗菌性及び創傷治癒促進性を有する創傷治癒剤
RU2675628C2 (ru) * 2016-12-23 2018-12-21 Общество с ограниченной ответственностью "Технофарм" Композиция, содержащая протеинат серебра, и способ ее производства
CA3020197C (en) 2017-09-01 2024-06-04 Micropure, Inc. Aliphatic anionic compounds and oxidative compounds with improved stability and efficacy for use in pharmaceutical compositions
WO2019049150A1 (en) * 2017-09-07 2019-03-14 Technion Research & Development Foundation Limited KITS AND TOPICAL COMPOSITIONS AND THEIR USE
EP3706619B1 (en) 2017-11-09 2024-04-24 ConvaTec Technologies Inc. Ostomy monitoring system
KR20210018898A (ko) * 2018-06-08 2021-02-18 패러데이 파마슈티컬스, 인코포레이티드 조직 손상 및 집중 치료 후 증후군의 치료 및 예방을 위한 할로겐 화합물의 용도
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
WO2020136552A1 (en) 2018-12-27 2020-07-02 3M Innovative Properties Company Antimicrobial compositions with 1,2-alkanediols
WO2021019336A1 (en) * 2019-07-29 2021-02-04 3M Innovative Properties Company Antimicrobial compositions and articles comprising the same
US20220046927A1 (en) * 2020-08-13 2022-02-17 Tom Johnson Disinfectant compositions and methods of making and using the same
JP2023545504A (ja) 2020-10-15 2023-10-30 コンバテック・テクノロジーズ・インコーポレイテッド オストミーシステムおよび方法
WO2022244013A1 (en) * 2021-05-21 2022-11-24 Prerna Goradia Light stable silver containing near neutral ph disinfectant and method of preparation
WO2024030261A1 (en) * 2022-08-04 2024-02-08 Seifert Kevin J Antimicrobial formulations and their methods for use

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396514A (en) 1943-03-20 1946-03-12 Ludwig Jekels Sterilizing materials and methods for making the same
GB735462A (en) * 1951-12-20 1955-08-24 Dow Chemical Co Improvements in or relating to iodine-containing ethylenediaminetetraacetic acid compounds and methods of making same
US2785106A (en) 1952-08-16 1957-03-12 Ions Exchange And Chemical Cor Process for making antiseptic article
US3092552A (en) 1958-05-19 1963-06-04 Albert C Nolte Oligodynamic silver compositions and uses
US3061469A (en) 1959-11-05 1962-10-30 Givaudan Corp Antibacterial textile fabrics
US3246624A (en) 1965-02-05 1966-04-19 Novo Ind Corp Pressure indicating device
US4258056A (en) 1978-12-18 1981-03-24 Economics Laboratory, Inc. Control of mastitis and compositions therefor
JPS6015641B2 (ja) 1981-03-18 1985-04-20 花王株式会社 繊維状カルボキシメチルセルロ−スの製造方法
EP0124536A4 (en) 1982-11-05 1985-06-06 Baxter Travenol Lab ANTIMICROBIAL COMPOSITIONS.
US4655758A (en) 1982-12-16 1987-04-07 Johnson & Johnson Products, Inc. Microbial polysaccharide articles and methods of production
US4889654A (en) 1984-07-31 1989-12-26 Rio Linda Chemical Company, Inc. Aqueous foam disinfectant containing chlorine dixoide and preparation and use thereof
US4612337A (en) 1985-05-30 1986-09-16 The Trustees Of Columbia University In The City Of New York Method for preparing infection-resistant materials
US4728323A (en) 1986-07-24 1988-03-01 Minnesota Mining And Manufacturing Company Antimicrobial wound dressings
FR2604900B1 (fr) * 1986-10-08 1989-01-13 Blomet Marie Claude Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
GB8709498D0 (en) 1987-04-22 1987-05-28 Bay M Wound dressing
US4829129A (en) 1987-05-29 1989-05-09 International Dioxcide, Inc. Reaction product of polymer with chlorine dioxide
GB2220881B (en) 1988-04-28 1992-07-08 Toyo Boseki Improvements in or relating to superabsorbent materials
US4906100A (en) 1988-05-13 1990-03-06 University Of Cincinnati Method of detecting adriamycin (doxorubicin) or daunomycin in the environment
RU2092180C1 (ru) 1988-06-22 1997-10-10 Эпплаид Микробиолоджи Инк. Антимикробная композиция
US4973848A (en) 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
US5340924A (en) 1990-01-18 1994-08-23 Morinaga Milk Industry Co., Ltd. Method for heat treatment of lactoferrin without losing physiological activities thereof
US6066469A (en) 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
AU656384B2 (en) 1991-04-10 1995-02-02 Christopher C. Capelli Antimicrobial compositions useful for medical applications
US5662913A (en) 1991-04-10 1997-09-02 Capelli; Christopher C. Antimicrobial compositions useful for medical applications
GB9126193D0 (en) 1991-12-10 1992-02-12 Courtaulds Plc Cellulosic fibres
US5407656A (en) 1992-03-04 1995-04-18 Arco Research Co., Inc. Method and compositions for the production of chlorine dioxide
AU669163B2 (en) 1992-03-20 1996-05-30 Unilever Plc Aqueous cleaning composition containing protein binding dye
US5762620A (en) 1992-04-02 1998-06-09 Ndm Acquisition Corp. Wound dressing containing a partially dehydrated hydrogel
PL173758B1 (pl) 1992-07-22 1998-04-30 Unilever Nv Sposób niszczenia mikroorganizmów osadzonych na powierzchni
AU5541594A (en) 1992-10-21 1994-05-09 Gynetech Laboratories, Inc. Vaginal sponge delivery system
WO1994016746A1 (en) 1993-01-22 1994-08-04 Courtaulds Plc Wound dressings
GB9301258D0 (en) 1993-01-22 1993-03-17 Courtaulds Plc Use of absorbent fibre
US5848995A (en) 1993-04-09 1998-12-15 Walder; Anthony J. Anti-infective medical article and method for its preparation
US5567495A (en) 1993-08-06 1996-10-22 The Trustees Of Columbia University In The City Of New York Infection resistant medical devices
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
JP3121503B2 (ja) 1994-10-18 2001-01-09 レンゴー株式会社 抗菌剤
JP3297969B2 (ja) 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5616347A (en) 1995-02-14 1997-04-01 Alliger; Howard Chlorine dioxide skin medicating compositions for preventing irritation
SE506869C2 (sv) 1995-06-30 1998-02-23 Inst Polymerutveckling Ab Metod för laminering genom fotoympning, laminat framställt enligt metoden samt dess användning
US5744151A (en) 1995-06-30 1998-04-28 Capelli; Christopher C. Silver-based pharmaceutical compositions
DE19609143C1 (de) 1996-03-08 1997-11-13 Rhodia Ag Rhone Poulenc Melt-blown-Vlies, Verfahren zu dessen Herstellung und dessen Verwendungen
US5820918A (en) 1996-07-11 1998-10-13 Hercules Incorporated Medical devices containing in-situ generated medical compounds
CA2263473C (en) 1996-08-16 2003-04-22 Christopher C. Capelli Silver-based antimicrobial compositions
US20030104018A1 (en) * 1996-12-31 2003-06-05 Griscom Bettle Skin product having micro-spheres, and processes for the production thereof
US6268544B1 (en) 1997-04-11 2001-07-31 Bristol-Myers Squibb Company Knitted wound dressings and method for making same
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US5993864A (en) * 1997-07-11 1999-11-30 Kross; Robert D. Chlorine dioxide chelate compositions and method of use
US5860947A (en) 1997-08-20 1999-01-19 Stamler; Keith D. Wound irrigation device and method
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US6753063B1 (en) 1997-11-19 2004-06-22 The Procter & Gamble Company Personal cleansing wipe articles having superior softness
IL123437A0 (en) 1998-02-24 1998-09-24 Shalev Pinchas Apparatus and method for photothermal destruction of oral bacteria
EP1091770A1 (en) 1998-07-01 2001-04-18 Acordis Speciality Fibres Limited Wound dressings and materials suitable for use therein
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
DE19909214A1 (de) 1999-03-03 2000-09-07 Basf Ag Wasserabsorbierende, schaumförmige, vernetzte Polymerisate mit verbesserter Verteilungswirkung, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9905663D0 (en) 1999-03-12 1999-05-05 Bristol Myers Squibb Co Iodine preparation composition
US6172040B1 (en) 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
ES2222231T3 (es) 1999-09-27 2005-02-01 Bhk Holding Ltd. Tejido absorbente.
AU7989100A (en) 1999-10-01 2001-05-10 Acrymed Silver-containing compositions, devices and methods for making
US6592890B1 (en) 1999-10-20 2003-07-15 Oxibio, Inc. Conveyance of anti-infective activity to wound dressings
US6555508B1 (en) 2000-02-17 2003-04-29 Leonard Paul Liquid foaming soap compositions
WO2001062289A2 (en) 2000-02-26 2001-08-30 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
CA2386985A1 (en) 2000-08-11 2002-02-21 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
US20070003508A1 (en) * 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20020091074A1 (en) * 2000-09-20 2002-07-11 Wooley Richard E. Medical compositions, dressings and methods for treating microbial infections of skin lesions
GB2370226A (en) 2000-09-21 2002-06-26 Acordis Speciality Fibres Ltd Wound dressing
PL205795B1 (pl) 2000-11-29 2010-05-31 Bristol Myers Squibb Co Sposób wytwarzania stabilizowanego światłem materiału o działaniu przeciwko drobnoustrojom
US20020172709A1 (en) 2001-03-30 2002-11-21 Brian Nielsen Medical dressing comprising an antimicrobial silver compound and a method for enhancing wound healing
WO2003022317A1 (en) 2001-09-12 2003-03-20 Acordis Speciality Fibres Limited Antibacterial wound dressing
GB2382527A (en) 2001-12-03 2003-06-04 Acordis Speciality Fibres Ltd Wound dressings
US8541472B2 (en) * 2001-12-05 2013-09-24 Aseptica, Inc. Antiseptic compositions, methods and systems
AU2002353061B2 (en) 2001-12-05 2008-07-10 Aseptica, Inc. Anti-microbial systems and methods
SK3313U (sk) * 2002-02-11 2002-10-08 Unimed Pharma Spol Sro Očná instilácia na báze jódového aniónu
US6468965B1 (en) 2002-04-22 2002-10-22 Paul Cutler Pharmaceutical composition for oral administration of a mixture of chelating agents
US20040033916A1 (en) 2002-06-28 2004-02-19 Kuzmin Vladimir Semenovich Disinfecting composition
GB0215023D0 (en) * 2002-06-28 2002-08-07 Bristol Myers Squibb Co Wound dressing
WO2004028461A2 (en) 2002-09-25 2004-04-08 Edwin Odell Miner Antiseptic solutions containing silver chelated with polypectate and edta
CN100384971C (zh) 2002-10-14 2008-04-30 阿科尼亚有限公司 组合物
CA2510784A1 (en) * 2002-12-19 2004-07-08 University Of Georgia Research Foundation, Inc. Methods and compositions for wound management
US7629000B2 (en) 2003-05-13 2009-12-08 E.I. Du Pont De Nemours And Company Method for making antimicrobial polyester-containing articles with improved wash durability and articles made thereby
WO2005041861A2 (en) 2003-08-28 2005-05-12 Pure Bioscience Anhydrous silver dihydrogen citrate compositions
US20050059731A1 (en) 2003-09-16 2005-03-17 Ceramoptec Industries, Inc. Erythrosin-based antimicrobial photodynamic therapy compound and its use
US7033511B2 (en) 2004-01-20 2006-04-25 A-Dec, Inc. Sustained water treatment in dental equipment
WO2005079582A1 (en) * 2004-02-24 2005-09-01 Campina B.V. Antimicrobial lactoferrin compositions for surfaces, cavities, and foodstuff
WO2005099757A1 (de) 2004-04-16 2005-10-27 Helbo Photodynamic Systems Gmbh & Co.Kg Aufbereitung für photodynamische bekämpfung von mikroorganismen und verwendung der aufbereitung
CN101039689B (zh) 2004-06-12 2013-01-30 西格纳姆生物科学公司 用于上皮相关病症的局部组合物和方法
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
EP1614790B1 (en) 2004-07-09 2008-10-08 JOHNSON & JOHNSON GmbH An absorbent personal care product for cosmetic and/or dermatological applications comprising at least one absorbent sheet
CN101022852A (zh) 2004-07-22 2007-08-22 恩迪尼国际有限公司 用于牙科应用的声光动力治疗
CN101010004B (zh) 2004-07-30 2012-10-03 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
US20060051430A1 (en) 2004-09-07 2006-03-09 Arata Andrew B Silver dihydrogen citrate compositions
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060115440A1 (en) 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
CA2593482A1 (en) 2005-01-14 2006-07-20 Neurogen Corporation Heteroaryl substituted quinolin-4-ylamine analogues
US20060234959A1 (en) 2005-04-14 2006-10-19 Advanced Photodynamic Technologies, Inc. Photodynamic therapy utilizing multiple duty cycle light modulation
FR2884422B1 (fr) 2005-04-18 2008-04-11 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
US20060254988A1 (en) 2005-05-10 2006-11-16 Confirm Monitoring Systems, Inc. Methods and compositions for the treatment of water
GB0513552D0 (en) 2005-07-01 2005-08-10 Bristol Myers Squibb Co Bandage
JP3877174B1 (ja) 2005-09-13 2007-02-07 株式会社オーバル 弾性連結部材及び台座を有する三次モード振動の直管式コリオリ流量計
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
JP2007167266A (ja) 2005-12-21 2007-07-05 Lion Corp 歯垢検出システムおよび歯垢検出方法
US20070166399A1 (en) 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
WO2007120608A2 (en) 2006-04-11 2007-10-25 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
JP4826382B2 (ja) 2006-08-08 2011-11-30 アルケア株式会社 抗菌性セルロース繊維及び皮膚接触用繊維製品
WO2008035734A1 (en) 2006-09-21 2008-03-27 Alcare Co., Ltd. Antibacterial fiber, method for production of the fiber, antibacterial fiber product comprising the antibacterial fiber, method for production of the product, and method for reproduction of the product
US9034352B2 (en) 2006-11-14 2015-05-19 Rohm And Haas Company Microbicide combinations containing silver
US20080226724A1 (en) 2007-01-19 2008-09-18 Genentech, Inc. Prevention of hydrogel viscosity loss
GB0710846D0 (en) 2007-06-06 2007-07-18 Bristol Myers Squibb Co A wound dressing
GB0805162D0 (en) 2008-03-19 2008-04-23 Bristol Myers Squibb Co Antibacterial wound dressing
WO2009130608A2 (en) 2008-04-24 2009-10-29 Uti Limited Partnership Combination of copper cations with peroxides or quaternary ammonium compounds for the treatment of biofilms
CN102099671A (zh) 2008-05-20 2011-06-15 大学健康网络 用于基于荧光的成像和监测的装置和方法
US9221963B2 (en) 2008-11-27 2015-12-29 Speciality Fibres And Materials Ltd. Absorbent material
GB0823265D0 (en) 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
US20100310845A1 (en) 2009-06-03 2010-12-09 Eric Bryan Bond Fluid permeable structured fibrous web
GB2474694B (en) 2009-10-23 2011-11-02 Innovia Films Ltd Biodegradable composites
US20110237994A1 (en) 2010-03-25 2011-09-29 Combat Medical Systems, Llc Void-filling wound dressing
ES2659543T3 (es) 2010-11-01 2018-03-16 Becton Dickinson And Company Ensayo de Gardnerella vaginalis
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
GB201105829D0 (en) 2011-04-06 2011-05-18 Convatec Technologies Inc Antimicrobial compositions
GB201308770D0 (en) 2013-05-15 2013-06-26 Convatec Technologies Inc Wound Dressing Comprising an Antimicrobial Composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013209385A (ja) * 2005-12-14 2013-10-10 Convatec Technologies Inc 抗菌組成物

Also Published As

Publication number Publication date
US20150306055A1 (en) 2015-10-29
AU2006325408A1 (en) 2007-06-21
JP6509948B2 (ja) 2019-05-08
ES2622827T3 (es) 2017-07-07
US20170079276A1 (en) 2017-03-23
CA2632939C (en) 2016-06-07
US10493101B2 (en) 2019-12-03
JP2009519312A (ja) 2009-05-14
PT1959739T (pt) 2017-04-24
EP1959739B1 (en) 2017-03-29
JP6348892B2 (ja) 2018-06-27
US9149035B2 (en) 2015-10-06
US20070190176A1 (en) 2007-08-16
PL1959739T3 (pl) 2017-07-31
JP2016040294A (ja) 2016-03-24
HUE032810T2 (en) 2017-11-28
WO2007068938A3 (en) 2008-09-18
EP1959739A2 (en) 2008-08-27
LT1959739T (lt) 2017-04-25
HK1246086A1 (en) 2018-09-07
JP2013209385A (ja) 2013-10-10
GB0525504D0 (en) 2006-01-25
WO2007068938A2 (en) 2007-06-21
US9545390B2 (en) 2017-01-17
NZ568999A (en) 2011-12-22
CA2632939A1 (en) 2007-06-21
EP3241439A1 (en) 2017-11-08
JP2017214386A (ja) 2017-12-07
DK1959739T3 (en) 2017-05-01
EP3241439B1 (en) 2020-12-02

Similar Documents

Publication Publication Date Title
JP6348892B2 (ja) 抗菌組成物
Percival et al. Antiseptics for treating infected wounds: efficacy on biofilms and effect of pH
US20220030875A1 (en) Composition comprising antimicrobial metal ions and a quaternary cationic surfactant
Burrell A scientific perspective on the use of topical silver preparations
US20130171224A1 (en) Treatment of biofilms
JP2019515961A (ja) 抗菌組成物
Gmur et al. Povidone-iodine in wound healing and prevention of wound infections
US20100203028A1 (en) Antimicrobial compositions
AU2006325408B2 (en) Antimicrobial composition
AU2013206810B2 (en) Antimicrobial composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091217

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20100326

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120327

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120626

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120703

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120726

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120802

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120824

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120926

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130508

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130701

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130723

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130807

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5340741

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees